pcDNA-HA-PfROM4 (H578A)
(Plasmid
#154858)
-
PurposeExpresses N-terminally HA-tagged PfROM4 variant H578A (codon optimized for mammalian expression) from pcDNA3.1
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 154858 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA 3.1
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5500
- Total vector size (bp) 7900
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namePfROM4
-
Alt nameRhomboid protease ROM4
-
SpeciesSynthetic
-
Insert Size (bp)2400
-
MutationHistidine 578 changed to Alanine
-
GenBank IDDQ986370
-
Entrez GenePF3D7_0506900 (a.k.a. PF3D7_0506900)
- Promoter CMV
-
Tag
/ Fusion Protein
- triple HA (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site EcoRI (not destroyed)
- 3′ cloning site NotI (not destroyed)
- 5′ sequencing primer T7 forward
- 3′ sequencing primer BGH reverse (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA-HA-PfROM4 (H578A) was a gift from Sinisa Urban (Addgene plasmid # 154858 ; http://n2t.net/addgene:154858 ; RRID:Addgene_154858) -
For your References section:
Designed Parasite-Selective Rhomboid Inhibitors Block Invasion and Clear Blood-Stage Malaria. Gandhi S, Baker RP, Cho S, Stanchev S, Strisovsky K, Urban S. Cell Chem Biol. 2020 Aug 31. pii: S2451-9456(20)30333-0. doi: 10.1016/j.chembiol.2020.08.011. 10.1016/j.chembiol.2020.08.011 PubMed 32888502